Where does Biosynth AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biosynth AG ranks #34,504 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biosynth AG hold?

Biosynth AG holds 7 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is Biosynth AG's Innovation Score?

Biosynth AG has an Innovation Score of 39.1 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Biosynth AG focus on?

Biosynth AG's top technology area is C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids) with 4 patents, ranking #217 of 896 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Biosynth AG's patent grant rate increasing or decreasing?

Biosynth AG's recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Biosynth AG's patents?

Biosynth AG's patents average 14.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biosynth AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biosynth AG

USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biosynth ranks #34,504 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 8 technology areas.

#34,504
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.1/100): 14.3
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R34504 · Foreign Corporation #34,504 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #34,504/49,997
PHOTO-FINISH Biochemical…
CPC-NARROW C07H · 8 areas
INNOV-THIN 39.1/100
CLAIMS-RICH 14.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Biochemical Diagnostics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biosynth’s 39.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (18%) Velocity 13.3 pts (34%) Breadth 10.0 pts (26%) Claim depth 8.6 pts (22%)

Qualcomm Incorporated · highest

85
Biosynth · this assignee

39
3D Lighting… · lowest

7

What this shows Biosynth's Innovation Score is 39.1/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biosynth?

Each dot is one of Biosynth’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biosynth’s own 14.3 claims/patent is at or below the 17.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Biosynth vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biosynth's grants concentrate

Biosynth AG is a focused PatentsView assignee: 8 CPC subclasses with 57.1% of grants classified under C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2023. By volume, Biosynth sits between Biochemical Diagnostics, Inc. and Bittium Wireless Oy.

Biosynth's three-year grant acceleration

Biosynth AG shows 2 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Biochemical Diagn…

7
Biodot

7
Biomet SAS

7
Biometric Payment…

7
Biotek Environmen…

7
Biotras Holdings

7
Bioz

7
Bittium Wireless…

7
Biosynth ◀

7

What this shows Biosynth holds 7 patents at rank #34,546, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biosynth

By rank, the assignees closest to #34,546 in granted patent volume.

Leaders in C07H (Sugars)

Other assignees with the most granted patents in Biosynth's primary technology class.

Biosynth's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biosynth AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	42.9%
2023	1	14.3%
2024	1	14.3%
2025partial year	2	28.6%

Which technologies does Biosynth AG patent most?

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 4

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

C07D - Heterocyclic Compounds 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C09B - Organic Dyes OR Closely-related Compounds FOR Producing Dyes ; , e.g. PIGMENTS; MORDANTS; Lakes 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biosynth AG's patent record in context - here's where to go next.

Biosynth AG's lead technology class is C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids), 57.1% of its portfolio - see every assignee active in that class. Explore C07H
Ranked #34,504 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biosynth AG against Biochemical Diagnostics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.